| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 03/08/2007 | CA2620742A1 Thiomorpholine compound and process for preparing the same |
| 03/08/2007 | CA2620647A1 Combined preparation of a thiazide diuretic and a loop diuretic |
| 03/08/2007 | CA2620255A1 Use of enoxaparin for performimg percutaneous coronary intervention |
| 03/08/2007 | CA2619912A1 Novel cycloalkane carboxamides as factor xa inhibitors |
| 03/07/2007 | EP1759718A1 Tissue closing preparation |
| 03/07/2007 | EP1759709A1 Humanized antibodies against leukocyte adhesion molecule VLA-4 |
| 03/07/2007 | EP1759695A1 Lactate containing pharmaceutical composition and uses thereof |
| 03/07/2007 | EP1758915A2 Composition and method for inhibiting platelet aggregation |
| 03/07/2007 | EP1758608A2 Conjugates of hydroxyethyl starch and erythropoietin |
| 03/07/2007 | EP1758568A1 System and method for transdermal delivery of an anticoagulant |
| 03/07/2007 | EP1427728B1 6,7-DIHYDRO-5H-PYRAZOLO 1,2-A PYRAZOL-1-ONES WHICH CONTROL INFLAMMATORY cYTOKINES |
| 03/07/2007 | EP1368304B1 Prodrugs of excitatory amino acids |
| 03/07/2007 | EP1333840B1 M. tuberculosis chaperonin 60.1 and uses thereof |
| 03/07/2007 | EP1228202B1 Antisense compositions and cancer-treatment methods |
| 03/07/2007 | EP1194528B1 Monoclonal antibody for factor VIII, which even when present in molar excess inactivates factor VIII only in part and a method for producing such an antibody |
| 03/07/2007 | EP1032387B1 Novel metal complexes |
| 03/07/2007 | EP1001970B1 Dipeptide derivatives as growth hormone secretagogues |
| 03/07/2007 | CN1926137A Pyrrole-derivatives as factor Xa inhibitors |
| 03/07/2007 | CN1925861A Composition containing benzamidine derivative and method for stabilizing benzamidine derivative |
| 03/07/2007 | CN1924013A Prourokinase modifier, preparation method, pharmaceutical composition, use, encoding gene, carrier containing gene and transformation cell |
| 03/07/2007 | CN1923996A Apirulina containing spirulina bioactive peptide and spirulina proteinase, preparation method and application thereof |
| 03/07/2007 | CN1923835A Polymorphs of clopidogrel hydrogensulfate |
| 03/07/2007 | CN1923797A Pharmaceutical compounds |
| 03/07/2007 | CN1923220A Ginkgo damo powder injection and its preparing process |
| 03/07/2007 | CN1923214A Preparation of sheep placenta peptide |
| 03/07/2007 | CN1923210A Diructose anhydride-containing composition and use thereof |
| 03/07/2007 | CN1303074C Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 03/07/2007 | CN1303072C 7-oxo pyridopyrimidines |
| 03/07/2007 | CN1302776C Peptide arginals and methods for treating disseminated intravascular coagulation |
| 03/07/2007 | CN1302774C Efferverscent tablets containing troxerutin and their preparation |
| 03/06/2007 | US7186838 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 03/06/2007 | US7186833 Such as 4-(4-hydroxyphenyl)butylamidino-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride; time-release agents; for therapy of chronic bronchitis, emphysema, cystic fibrosis, and eye disorders |
| 03/06/2007 | US7186753 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents |
| 03/06/2007 | US7186752 Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 03/06/2007 | US7186748 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 03/06/2007 | US7186737 Inhibitors of p38 |
| 03/06/2007 | US7186734 Binding to antagonist or inverse antagonist as antiinflammatory agentsand immunological disorders |
| 03/06/2007 | US7186720 Moderator of tumor necrosis factor; antiinflammatory agents; autoimmune diseases |
| 03/06/2007 | US7186717 Pyrrolidine derivatives as Factor Xa inhibitors |
| 03/06/2007 | US7186710 PDE4/7 inhibitors useful in treatment of airway disorders, autoimmune system disorders, skin disorders, arthritis, nerve system disorders |
| 03/01/2007 | WO2007024008A1 Preventive or therapeutic agent for side effect based on cytotoxicity of anticancer therapy containing apoptosis inhibition activity-enhancing protein fnk or nucleic acid encoding the same |
| 03/01/2007 | WO2007024004A1 Phenylpyridone derivative |
| 03/01/2007 | WO2007023880A1 Chemokine production inhibitor |
| 03/01/2007 | WO2007023729A1 Sustained-release preparation |
| 03/01/2007 | WO2007023154A2 Iron (iii) complex compounds for treating iron deficiency in patients with chronic inflammatory intestinal diseases |
| 03/01/2007 | WO2007022784A2 Liquid factor vii composition |
| 03/01/2007 | WO2007002637B1 N-linked heterocyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 03/01/2007 | WO2006138347A3 Androgen receptor modulator compounds and methods |
| 03/01/2007 | US20070049735 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070049601 BENZOFURAN INHIBITORS OF FACTOR VIIa |
| 03/01/2007 | US20070049566 Methods and Compositions for inhibition of angiogenesis |
| 03/01/2007 | US20070048319 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070048298 administering nucleoproteins such as retinoblastoma associated protein 48 suppressor or inhibitors, used for prophylaxis of Sjogren's syndrome, as diagnostic agents or screening antiapoptosic agents |
| 03/01/2007 | US20070048221 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070048220 Antibodies that bind both bcma and taci |
| 03/01/2007 | CA2622904A1 Self-assembling nanoparticles for the treatment of vascular diseases |
| 03/01/2007 | CA2620259A1 Sustained-release preparation |
| 03/01/2007 | CA2619770A1 Phenylpyridone derivative |
| 03/01/2007 | CA2617510A1 Use of iron (iii) complex compounds for the preparation of a medicament for oral treatment of iron deficiency states in patients with chronic inflammatory bowel disease |
| 02/28/2007 | EP1757614A1 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
| 02/28/2007 | EP1757300A1 Agent for removing factor causing circulatory dysfunction |
| 02/28/2007 | EP1757299A1 Complexes of iron III for treating iron deficiencies in patients with inflammatory bowel disease |
| 02/28/2007 | EP1757289A1 Composition for acceleration of alcohol metabolism or recuperation from fatigue through gluconeogenesis |
| 02/28/2007 | EP1757282A1 The use of kauranes compounds in the manufacture of medicament |
| 02/28/2007 | EP1756068A1 Benzimidazoles, method for producing them and the use thereof as drugs |
| 02/28/2007 | EP1755682A1 Solid pharmaceutical formulation |
| 02/28/2007 | EP1755652A1 Factor ixa for the treatment of bleeding disorders |
| 02/28/2007 | EP1755642A1 Annexin v for preventing atherothrombois and plaque rupture |
| 02/28/2007 | EP1755594A1 Combination therapy comprising an adenosine a1 receptor antagonist and an aldosterone inhibitor |
| 02/28/2007 | EP1492771B1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents |
| 02/28/2007 | EP1343561B1 Serine protease inhibitors |
| 02/28/2007 | EP1123313B1 Methods and compositions for the prevention and treatment of anemia |
| 02/28/2007 | EP0833840B1 Hypoxia inducible factor-1 and method of use |
| 02/28/2007 | CN1922171A Pyrimidine derivative |
| 02/28/2007 | CN1922139A Bicyclic amide derivatives |
| 02/28/2007 | CN1921870A Artificial physiological salt solution and process for producing the same |
| 02/28/2007 | CN1921847A 氨基醇化合物 Amino alcohol compound |
| 02/28/2007 | CN1919856A Caulis trachelospermi total lignans extractive, extraction method and medicine use of the extractive and active constituent thereof |
| 02/28/2007 | CN1919848A bilobalide K and complex thereof, preparation method and use for the same |
| 02/28/2007 | CN1919339A Cucurbitacin nano preparation comprising protein, preparation method and use thereof |
| 02/28/2007 | CN1919335A Albumen powder capsule |
| 02/28/2007 | CN1919278A Blood activating oil and its preparation method |
| 02/28/2007 | CN1919222A Process for preparing notoginsen triterpenes |
| 02/28/2007 | CN1919219A Refining method of ginko total chromocor and method for preparing ginko damo injection |
| 02/28/2007 | CN1919210A System for the liberation of an active principle and its use |
| 02/28/2007 | CN1919207A Gariic and medlar capsule |
| 02/28/2007 | CN1919197A Slow release drop pills comprising toraesmide active ingredient and method for preparing same |
| 02/28/2007 | CN1919196A Slow release tablet comprising toraesmide active ingredient |
| 02/28/2007 | CN1302102C Method for preparing megakaryocytic preparation by amplifying macronucleus ancestral cell and mature megacaryocyte and use |
| 02/28/2007 | CN1301973C Heterocyclic derivatives and medicines |
| 02/28/2007 | CN1301969C New mandelic acid derivatives and their use as thrombin inhibitors |
| 02/28/2007 | CN1301724C Medicine for thrombotic diseases |
| 02/28/2007 | CN1301707C Danhong freeze dried powder injection agent and its preparation method |
| 02/27/2007 | US7183436 Substituted 4-aminocyclohexanols |
| 02/27/2007 | US7183307 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/27/2007 | US7183297 For therapy of rheumatoid arthritis, osteoarthritis, asthma, psoriasis, eczema, allergic rhinitis, allergic conjunctivitis, adult respiratory distress syndrome, chronic pulmonary inflammation, chronic obstructive pulmonary disease, chronic heart failure, silicosis, endotoxemia, toxic shock syndrome |
| 02/27/2007 | US7183288 2-phenylamino-4-pyrimidinecarboxamides; coupling a phenylamine with a halopyrimidine, or coupling a halobenzene with an aminopyrimidine, or amidating the 2-phenylamino-4-pyrimidylacylhalide, or oxidizing the 2-phenylamino-4-cyanopyrimidine |
| 02/27/2007 | US7183277 Alpha-((aryl or heteroaryl)ureido or carbamoyloxy)-N-heteroaryl amides; blood-coagulation factor Xa and VIIa inhibitors; synergistic mixtures with other antitumor agents or anticoagulants |
| 02/27/2007 | US7183271 Vasopressin active materials; antidiabetic agents; diuretics; bioavailability |
| 02/27/2007 | US7183264 Such as ethyl-1-(9-((4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxy-methyl)oxolan-2-yl)-6 -aminopurin-2-yl)pyrazole-4-carboxylate; adenosine receptors (A2A); for stimulating mammalian coronary vasodilatation for therapy and imaging the heart |